17 Results for "

antiglaucoma

" in MedChemExpress (MCE) Product Catalog:
Products (17)

17 Results for "antiglaucoma" in MCE Product Catalog:

Cat. No.: HY-B0600
CAS No.: 209860-87-7
Synonyms: AFP-168; MK2452
Research Areas:  

Cardiovascular Disease Others

Tafluprost (AFP-168) is an anti-glaucoma prostaglandin (PG) analog. Tafluprost can inhibit the apoptosis of retinal ganglion cells (RGCs) and rat RGCs cells. Tafluprost promotes axon regeneration by regulating Zn 2+-mTORpathway, inhibits intracellular lipid accumulation in human preorbital adipocytes. Tafluprost can be used in the study of optic nerve injury in glaucoma .
loading...
    loading...
Cat. No.: HY-B1323
CAS No.: 64019-93-8
Synonyms: Dipivefrine hydrochloride
Dipivefrin hydrochloride (Dipivefrine hydrochloride) is an antiglaucoma proagent that is hydrolyzed to the active compound, epinephrine, by esterases in the cornea .
loading...
    loading...
Cat. No.: HY-109545
CAS No.: 120373-24-2
Purity:  95.1%
Synonyms: Unoprostone isopropyl ester; UF-021
Target:  

Potassium Channel

Research Areas:  

Others

Isopropyl unoprostone (Unoprostone isopropyl ester), an analogue of a prostaglandin metabolite, is a potent large conductance Ca 2+-activated K + (BK) channels activator. Isopropyl unoprostone has antiglaucoma effects, lowering intraocular pressure (IOP) by increasing aqueous humour outflow. Isopropyl unoprostone can improve retinal sensitivity and the protection of central retinal sensitivity .
loading...
    loading...
Cat. No.: HY-115462
CAS No.: 863704-91-0
Purity:  98.90%
Research Areas:  

Inflammation/Immunology

PGN-9856 is a selective and high affinity (pKi ≥ 8.3) ligand at EP2 receptor. PGN-9856 is a potetn and non-prostanoid EP2 receptor agonist (pEC50 ≥ 8.5). PGN-9856 shows anti-inflammatory and anti-glaucoma activities .
loading...
    loading...
Cat. No.: HY-130395
CAS No.: 135646-98-9
Research Areas:  

Endocrinology

15-Keto latanoprost is a metabolite of Latanoprost, which is an ocular hypotensive agent .
loading...
    loading...
Cat. No.: HY-W031519
CAS No.: 121-30-2
Target:  

Carbonic Anhydrase

Research Areas:  

Cardiovascular Disease

Chloraminophenamide (Compound 14) is a carbonic anhydrase inhibitor, with Kis of 75, 160 and 8400 nM for hCA II, bCA IV and hCA I, respectively. Chloraminophenamide has the potential for antiglaucoma research .
loading...
    loading...
Cat. No.: HY-B1323R
CAS No.: 64019-93-8
Synonyms: Dipivefrine hydrochloride (Standard)
Dipivefrin (hydrochloride) (Standard) is the analytical standard of Dipivefrin (hydrochloride). This product is intended for research and analytical applications. Dipivefrin hydrochloride (Dipivefrine hydrochloride) is an antiglaucoma proagent that is hydrolyzed to the active compound, epinephrine, by esterases in the cornea .
loading...
    loading...
Cat. No.: HY-168802
CAS No.: 261179-75-3
Research Areas:  

Cardiovascular Disease

9-Keto tafluprost is a derivative of Tafluprost (HY-B0600). Tafluprost is an anti-glaucoma prostaglandin (PG) analog .
loading...
    loading...
Cat. No.: HY-118215
CAS No.: 1192760-33-0
Synonyms: AGN212409
Research Areas:  

Others

Aganepag ethanediol (AGN212409) is an EP2 (Prostaglandin Receptor) receptor agonist. Aganepag ethanediol may be used in anti-glaucoma research .
loading...
    loading...
Cat. No.: HY-B1323S
Synonyms: Dipivefrine-d6 hydrochloride
Dipivefrin-d6 (hydrochloride) is deuterium labeled Dipivefrin (hydrochloride). Dipivefrin hydrochloride (Dipivefrine hydrochloride) is an antiglaucoma proagent that is hydrolyzed to the active compound, epinephrine, by esterases in the cornea .
loading...
    loading...
Cat. No.: HY-144268
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

hCAII-IN-7 (Compound R-13) is a potent human carbonic anhydrase (hCA) inhibitor with Kis of 60.7, 320.7, 2298, and 35.2 nM for hCA I, II, IV and IX, respectively .
loading...
    loading...
Cat. No.: HY-124219
CAS No.: 1421369-12-1
Synonyms: 17-Phenoxy trinor PGF2α ethyl amide
Research Areas:  

Others

17-Phenoxy trinor prostaglandin F2α ethyl amide (17-Phenoxy trinor PGF2α ethyl amide) is an analog of Bimatoprost (HY-12956). 17-Phenoxy trinor prostaglandin F2α ethyl amide is an agonist for Prostaglandin F2α Receptor (FP receptor). 17-Phenoxy trinor prostaglandin F2α ethyl amide is potent to reduce the intraocular pressure and attenuate the glaucoma .
loading...
    loading...
Cat. No.: HY-124243
CAS No.: 1138395-10-4
Synonyms: 17-Phenyl trinor prostaglandin F2α cyclopropyl methyl amide
Research Areas:  

Others

N-Cyclopropyl methyl bimatoprost (17-Phenyl trinor prostaglandin F2α cyclopropyl methyl amide) is an analog of Bimatoprost (HY-12956). N-Cyclopropyl methyl bimatoprost is an agonist for Prostaglandin F2α Receptor (FP receptor). N-Cyclopropyl methyl bimatoprost is potent to reduce the intraocular pressure and attenuate the glaucoma .
loading...
    loading...
Cat. No.: HY-139420R
CAS No.: 1185851-52-8
Research Areas:  

Others

Tafluprost ethyl amide (Standard) is the analytical standard of Tafluprost ethyl amide (HY-139420). This product is intended for research and analytical applications. Tafluprost ethyl amide is a derivative of Tafluprost (HY-B0600). Tafluprost ethyl amide is commonly used in studies related to eyelash hypotrichosis, and it can also be applied in research related to the cosmetic field .
loading...
    loading...
Cat. No.: HY-B0600R
CAS No.: 209860-87-7
Synonyms: AFP-168 (Standard); MK2452 (Standard)
Tafluprost (Standard) is the analytical standard of Tafluprost. This product is intended for research and analytical applications. Tafluprost (AFP-168) is an anti-glaucoma prostaglandin (PG) analog. Tafluprost can inhibit the apoptosis of retinal ganglion cells (RGCs) and rat RGCs cells. Tafluprost promotes axon regeneration by regulating Zn2+-mTORpathway, inhibits intracellular lipid accumulation in human preorbital adipocytes. Tafluprost can be used in the study of optic nerve injury in glaucoma [4] .
loading...
    loading...
Cat. No.: HY-184937
COX-2/CA II-1 is an orally active dual selective inhibitor targeting COX-2 and hCA II. COX-2/CA II-1 inhibits COX-2 with an IC50 value of 0.13 μM (SI = 9.25 vs COX-1) and hCA II with a Ki value of 39.1 nM (SI = 933.8 vs hCA I). COX-2/CA II-1 demonstrates significant analgesic and anti-inflammatory effects in animal models, shows improved gastric safety with reduced ulcerogenic liability, and exhibits intraocular pressure (IOP)-lowering effects in rabbit glaucoma models. COX-2/CA II-1 can be used for anti-inflammatory, analgesic and antiglaucoma research .
loading...
    loading...
Cat. No.: HY-184938
COX-2/CA II-2 is an orally active dual selective inhibitor targeting COX-2 and hCA II. COX-2/CA II-2 inhibits COX-2 with an IC50 value of 0.05 μM (SI = 12.02 vs COX-1) and hCA II with a Ki value of 62.6 nM (SI = 704.2 vs hCA I). COX-2/CA II-2 demonstrates significant analgesic and anti-inflammatory effects with rapid onset and sustained duration in animal models, shows improved gastric safety with reduced ulcerogenic liability, and exhibits a gradual intraocular pressure (IOP)-lowering effect without statistical significance relative to the sham-treated eye in rabbit glaucoma models. COX-2/CA II-2 can be used for anti-inflammatory, analgesic and antiglaucoma research .
loading...
    loading...
  • 1